Search results

Selected filters:

Law & Policy
News

Article type

Topic

Sector

Regions

Year

300 results found for your search

Sort options
02 October 2018

Will China’s leaders get to grips with the patent incentive problem?

A state media article blasts ‘fast food-style innovation’ as abandonments data paints a bleak picture.

27 September 2018

New generation in SCOTUS and other US courts may mean more patent erosion, says CAFC justice

In keynote IPO speech, Kathleen O’Malley states that in the digital age judicial respect for IP is waning, but argues that rights holders can fight back through improved prosecution and enforcement

20 September 2018

At <em>IAM</em> event DOJ antitrust chief throws spotlight back onto SEP licensing

Violating a FRAND commitment should not give rise to an antitrust action under US law Delrahim insists as he looks for balance in debate around patent hold out and hold up.

13 September 2018

<strong>Chinese biotech patents fail to make mark, more litigation for AbbVie, AIDS Heath Foundation appeals to SCOTUS and much more</strong>

The August edition of our monthly round-up of the life sciences stories you need to know

12 September 2018

DoJ antitrust chief Delrahim headlines IAM’s Patent Licensing in San Francisco next week

Fourth edition of this annual event also boasts high-profile speakers from AT&T, Cisco, Ericsson, Google, Honda, IBM, Nokia, Qualcomm, Samsung Electronics – and many more

28 August 2018

How the Supreme Court’s newest justice has impacted patent law

Since joining America's highest court, Justice Gorsuch has revealed some of his thinking on patent issues and his overall judicial record provides some clues as to how he could view key cases if they come before the court.  

17 August 2018

Exit of PTAB chief judge gives Iancu further opportunity to put his own imprint on agency leadership

Key departure means there are three top roles to be filled on permanent basis.

09 August 2018

US pharma companies under increasing legislative pressure, key EU SPC decision and much more in July’s life sciences IP round-up

In this month’s round-up of patent news from the life sciences, we report on the latest blow to the St Regis Mohawks’ attempt shield their Restasis patents from inter partes review, the new bill seeking to roll out compulsory licensing in the US,…

08 August 2018

Just a week after the US mid-term elections, the 4th Patent Law and Policy event couldn't be more timely

The fourth annual Patent Law and Policy event returns to Washington DC in November. It will take place just after a vote that will affect key IP policymakers in the US Congress.

30 July 2018

Steep rise in the number of oppositions at the EPO matches a surge in grants

The number of oppositions proceedings at the European Patent Office is on the rise – with numbers for 2017 exceeding anything that has previously been seen. But while some may point to this indicating a decline in the quality of grants at the office…

20 July 2018

China and South Korea will displace the West as the world’s innovation leaders by 2029

New report claims status of US, EU and UK as leading innovators under threat as they struggle to maximise return on R&D investment. 

18 July 2018

Delrahim confirmed as keynote speaker at IAM's annual patent licensing event in September

Makan Delrahim, the assistant attorney general for the Antitrust Division of the US Department of Justice, has been comfirmed as the keynote speaker at Patent Licensing 2018, IAM's annual event focusing on the key issues affecting licensees and…

11 July 2018

Artificial intelligence and the future of the patent system

There are myriad issues facing the global patent system which, if not addressed, could lead to a decline in its use.  Ed White of Clarivate Analytics argues that a close focus on AI can help to mitigate these issues.

07 July 2018

All the big legal, market and deals news from the life sciences sector in June

In June’s round-up of life sciences-related news, we report on the US Supreme Court’s decision to grant certiorari in the Helsinn Healthcare v Teva Pharmaceuticals Section 102 dispute, but not in the Cleveland Clinic’s Section 101 case against True…

01 July 2018

Battistelli's achievements overshadow the mistakes he undoubtedly made

A new era gets underway at the European Patent Office tomorrow when Portugal’s Antonio Campinos takes over as its president in succession to Benoît Battistelli, who stepped down on Friday having been in charge since 2010.   It’s fair to say that…